ASH 2018 Coverage: A Scientist Shares Insight on Drug Development

Published on

Topics include: Treatments and Understanding

As part of our coverage of the 2018 American Society of Hematology (ASH) Annual Meeting, Dr. Phillip Liu, Senior Director at Incyte Corporation, joined Patient Power to discuss the discovery of Ruxolitinib (Jakafi). Dr. Liu shares the story of when the JAK2V617F mutation was identified and what later trials revealed. Tune in now to hear the back story of this groundbreaking treatment option for MPNs.

View more programs featuring and

Transcript

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Andrew Schorr:

So we started to investigate. So I remember exactly when he came back from the meeting and announced this finding in the room.  We were all filled with excitement but at the same time we looked around in puzzlement because none of us had ever heard of these diseases before, polycythemia vera or myelofibrosis, and that was really the beginning.  

Remember, knowledge can be the best medicine of all.  

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Related Programs

ASH 2018 Daily Wrap: MPN News

On location in San Diego, Patient Power founders Andrew and Esther Schorr are joined by a panel of experts to discuss research developments announced at ASH 2018. Watch day one of Patient Power’s daily wrap to hear the latest blood cancer-related treatment news.

Published:

MPN News From ASH 2018: Perspectives From Leading Experts

Tune in for ASH 2018 updates with MPN experts Dr. Srdan Verstovsek, Dr. Abdulraheem Yacoub and Lindsey Lyle as they discuss the latest news and developments related to MPN research and treatment.

Published:

Updates From ASH 2018: The Latest on Interferon Therapy in MPNs

MPN experts, Dr. Srdan Verstovsek and Dr. Abdulraheem Yacoub provide an update from ASH 2018, including the latest in interferon research for the treatment of polycythemia vera (PV).

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on January 11, 2019